Aura Biosciences, Inc.
AURA
$7.64
-$0.01-0.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -131.01M | -112.39M | -106.19M | -106.47M | -101.38M |
| Total Depreciation and Amortization | 1.09M | 1.11M | 1.13M | 1.15M | 1.18M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 23.42M | 14.88M | 14.35M | 13.62M | 11.96M |
| Change in Net Operating Assets | 3.50M | 5.12M | 5.97M | 3.47M | 4.89M |
| Cash from Operations | -103.01M | -91.28M | -84.74M | -88.23M | -83.35M |
| Capital Expenditure | -344.00K | -362.00K | -447.00K | -570.00K | -866.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -184.99M | 61.04M | 36.04M | 36.04M | 90.24M |
| Cash from Investing | -185.33M | 60.68M | 35.60M | 35.47M | 89.37M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 266.89M | 53.83M | 53.75M | 51.52M | 47.87M |
| Repurchase of Common Stock | -39.09M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 21.38M | 23.53M | 23.41M | 23.41M | 23.41M |
| Cash from Financing | 249.18M | 77.36M | 77.16M | 74.93M | 71.28M |
| Foreign Exchange rate Adjustments | -374.00K | -192.00K | -186.00K | -26.00K | -12.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -39.53M | 46.57M | 27.82M | 22.15M | 77.29M |